These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 29555397

  • 1. Thrombolytic Therapy in Severe Cardioembolic Stroke After Reversal of Dabigatran with Idarucizumab: Case Report and Literature Review.
    Ohya Y, Makihara N, Wakisaka K, Morita T, Ago T, Kitazono T, Takaba H.
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):e128-e131. PubMed ID: 29555397
    [Abstract] [Full Text] [Related]

  • 2. Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator.
    Bissig D, Manjunath R, Traylor BR, Richman DP, Ng KL.
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):e102-e104. PubMed ID: 28416406
    [Abstract] [Full Text] [Related]

  • 3. Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.
    Fang CW, Tsai YT, Chou PC, Chen HM, Lu CM, Tsao CR, Chen CL, Sun MC, Shih YS, Hsieh CY, Chen LA, Chen PL, Yeh JT, Li YH.
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):815-820. PubMed ID: 30573284
    [Abstract] [Full Text] [Related]

  • 4. Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment.
    Meyer D, Chu F, Derry K, Hailey L.
    J Clin Neurosci; 2019 Jan; 59():355-357. PubMed ID: 30309801
    [Abstract] [Full Text] [Related]

  • 5. Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran: a case report.
    Ohtani T, Sintoku R, Yajima T, Kaneko N.
    J Med Case Rep; 2019 Dec 26; 13(1):390. PubMed ID: 31875786
    [Abstract] [Full Text] [Related]

  • 6. Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report.
    Agosti S, Casalino L, Rocci E, Zaccone G, Rota E.
    J Med Case Rep; 2017 Aug 15; 11(1):224. PubMed ID: 28806993
    [Abstract] [Full Text] [Related]

  • 7. Systemic Thrombolysis in Acute Ischemic Stroke after Dabigatran Etexilate Reversal with Idarucizumab-A Case Report.
    Tireli D, He J, Nordling MM, Wienecke T.
    J Stroke Cerebrovasc Dis; 2017 Jul 15; 26(7):e123-e125. PubMed ID: 28479184
    [Abstract] [Full Text] [Related]

  • 8. Idarucizumab-facilitated intravenous thrombolysis in acute stroke with dabigatran: Two cases with hemorrhagic transformation.
    Tsai YT, Hsiao YJ, Tsai LK, Yen PS, Lin FY, Lu CH, Fang CW.
    J Neurol Sci; 2018 May 15; 388():155-157. PubMed ID: 29627012
    [No Abstract] [Full Text] [Related]

  • 9. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
    Pretnar Oblak J, Sabovic M, Frol S.
    J Stroke Cerebrovasc Dis; 2019 Mar 15; 28(3):768-773. PubMed ID: 30527792
    [Abstract] [Full Text] [Related]

  • 10. Adverse clinical outcomes after dabigatran reversal with idarucizumab to facilitate acute stroke thrombolysis.
    Ng FC, Bice J, Rodda A, Lee-Archer M, Crompton DE.
    J Neurol; 2017 Mar 15; 264(3):591-594. PubMed ID: 28168523
    [No Abstract] [Full Text] [Related]

  • 11. Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab.
    Berrouschot J, Stoll A, Hogh T, Eschenfelder CC.
    Stroke; 2016 Jul 15; 47(7):1936-8. PubMed ID: 27301937
    [Abstract] [Full Text] [Related]

  • 12. Dabigatran Reversal With Idarucizumab Preceding Thrombolysis in an Octogenarian Patient with Chronic Kidney Disease and Acute Stroke: A Case Report.
    Laxamana LC, Co COC, Yu JRT, Mojica CV, Iboleon-Dy MAM, Domingo AMC, Ilano KCS, Macrohon-Valdez MCZ.
    Clin Ther; 2020 Sep 15; 42(9):1840-1845. PubMed ID: 32778345
    [Abstract] [Full Text] [Related]

  • 13. Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection.
    Kermer P, Eschenfelder CC, Diener HC, Grond M, Abdalla Y, Althaus K, Berrouschot J, Cangür H, Daffertshofer M, Edelbusch S, Gröschel K, Haase CG, Harloff A, Held V, Kauert A, Kraft P, Lenz A, Müllges W, Obermann M, Partowi S, Purrucker J, Ringleb PA, Röther J, Rossi R, Schäfer N, Schneider A, Schuppner R, Seitz RJ, Szabo K, Wruck R.
    Int J Stroke; 2017 Jun 15; 12(4):383-391. PubMed ID: 28494694
    [Abstract] [Full Text] [Related]

  • 14. Reversal of dabigatran using idarucizumab: single center experience in four acute stroke patients.
    Hieber M, Hollasch H, Heck D, Mächtel M, Geisen U, Niesen WD, Brich J, Harloff A.
    J Thromb Thrombolysis; 2018 Jul 15; 46(1):12-15. PubMed ID: 29633066
    [Abstract] [Full Text] [Related]

  • 15. Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Thrombolytic Therapy.
    Kikule I, Baborikina A, Haritoncenko I, Karelis G.
    Medicina (Kaunas); 2022 Sep 27; 58(10):. PubMed ID: 36295516
    [Abstract] [Full Text] [Related]

  • 16. Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke.
    Beharry J, Waters MJ, Drew R, Fink JN, Wilson D, Campbell BCV, Parsons MW, Kleinig TJ, Wu TY.
    Stroke; 2020 May 27; 51(5):1616-1619. PubMed ID: 32208845
    [Abstract] [Full Text] [Related]

  • 17. Systemic Thrombolysis for Ischemic Stroke after Antagonizing Dabigatran with Idarucizumab-A Case Report.
    Schäfer N, Müller A, Wüllner U.
    J Stroke Cerebrovasc Dis; 2016 Aug 27; 25(8):e126-7. PubMed ID: 27236361
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Idarucizumab for Intravenous Thrombolysis and Endovascular Thrombectomy in Acute Stroke: A Case Report.
    Lin YT, Lai YJ, Lai TH.
    J Emerg Med; 2020 Mar 27; 58(3):e113-e116. PubMed ID: 31744711
    [Abstract] [Full Text] [Related]

  • 20. [The first use of iv. idarucizumab for dabigatran reversal in Hungary].
    Driesz L, Barabás É, Bodócs I, Szántó Z, Herr G, Bencsik G, Pál L, Borbola J.
    Orv Hetil; 2017 Mar 27; 158(10):387-392. PubMed ID: 28270004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.